Merck & Co. Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Merck & Co., Inc. income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue65.0164.1760.1259.2848.7041.5246.8442.29
Cost of Revenue12.0314.7016.1317.4113.6313.6214.1113.51
Gross Profit52.9849.4743.9941.8735.0827.9032.7328.79
Operating Expenses
Research & Development15.6014.4830.5313.5512.2513.409.879.75
Selling, General & Administrative10.6110.1010.5010.049.638.9610.6210.10
Operating Expenses26.2124.5841.0423.5921.8822.3520.4919.85
Operating Income26.7824.892.9518.2813.205.5512.248.93
Other Income/Expense
Interest Income-1.010.420.370.160.040.120.000.34
Interest Expense0.00-1.271.15-0.960.81-0.830.000.77
Other Income/Expense-5.710.29-0.28-1.03-1.34-0.890.140.20
Income
Income Before Tax21.0719.941.8916.4413.885.8611.468.70
Income Tax Expense2.802.801.511.921.521.341.692.51
Net Income18.2517.120.3714.5213.057.079.846.22
Net Income - Continuous Operations18.2517.130.3814.5312.360.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.700.000.000.00
EBITDA25.3629.136.9121.3217.9010.1816.0313.99
EBIT24.5024.893.0417.4114.696.6912.369.47
Depreciation & Amortization4.294.253.871.821.581.671.680.00
Earnings Per Share
Basic EPS7.007.00-6.005.003.004.002.00
Diluted EPS7.007.00-6.005.003.004.002.00
Basic Shares Outstanding2.512.532.612.532.532.532.572.66
Diluted Shares Outstanding2.512.542.612.542.542.542.582.68